Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
2007 · Breast Cancer Research · 605 citations
https://doi.org/10.1186/bcr1771
H
Harry Bartelink
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
453
Papers
37.5K
Citations
88
h-index
236
i10-index
Harry Bartelink is an academic researcher from The Netherlands Cancer Institute. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Advanced Radiotherapy Techniques. The author has an h-index of 88, co-authored 386 publications.
Papers by this author
worksRole of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
2017 · The Lancet Oncology · 331 citations
https://doi.org/10.1016/s1470-2045(17)30458-8
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
2016 · Clinical Cancer Research · 133 citations
https://doi.org/10.1158/1078-0432.ccr-15-2711
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer
2013 · BMC Cancer · 119 citations
https://doi.org/10.1186/1471-2407-13-84
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial
2015 · Radiotherapy and Oncology · 73 citations
https://doi.org/10.1016/j.radonc.2015.02.002
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis
2009 · Radiation Oncology · 57 citations
https://doi.org/10.1186/1748-717x-4-47
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat